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Abstract
Background: In order to reduce systematic errors (such as language bias) and increase the
precision of the summary treatment effect estimate, a comprehensive identification of randomised
controlled trials (RCT), irrespective of publication language, is crucial in systematic reviews and
meta-analyses. We identified trials in the German general health care literature.
Methods: Eight German language general health care journals were searched for randomised
controlled trials and analysed with respect to the number of published RCTs each year and the size
of trials.
Results: A total of 1618 trials were identified with a median total number of 43 patients per trial.
Between 1970 and 2004 a small but constant rise in sample size from a median number of 30 to 60
patients per trial can be observed. The number of published trials was very low between 1948 and
1970, but increased between 1970 and 1986 to a maximum of 11.2 RCTs per journal and year. In
the following time period a striking decline of the number of RCTs was observed. Between 1999
and 2001 only 0.8 RCTs per journal and year were published, in the next three years, the number
of published trials increased to 1.7 RCTs per journal and year.
Conclusion:  German language general health care journals no longer have a role in the
dissemination of trial results. The slight rise in the number of published RCTs in the last three years
can be explained by a change of publication language from German to English of three of the
analysed journals.
Background
Approximately more than 10,000 randomised controlled
trials (RCTs) – widely acknowledged as the gold standard
for the evaluation of medical interventions – are pub-
lished each year. Systematic reviews of RCTs, such as those
disseminated through the Cochrane Collaboration, syn-
thesise the results of individual trials to facilitate the use
of external evidence in clinical decision making. The proc-
ess of systematic reviewing is designed to maximise valid-
ity. This is accomplished with a series of steps to minimise
bias, such as a comprehensive literature search. Indeed,
the exhaustive identification of trials, irrespective of the
language of publication, seems important to reduce sys-
tematic errors like language bias. Studies investigating the
influence of language bias reveal controversial findings.
For the comparison of German and English-language tri-
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als, a significant trend towards publication of statistically
significant results in English-language journals was iden-
tified [1]. However, reanalysis of published meta-analysis
including both English and non-English language trials
found no consistent change in the summary estimates of
meta-analyses when excluding non-English language tri-
als. These findings, however, seem to depending on the
medical specialty. In complementary medicine several
meta-analyses resulted in significantly smaller summary
result estimates when excluding non-English language tri-
als [2-4]. Therefore, without consistent empirical evidence
supporting the exclusion of non-English language trials,
the set of eligible trials for systematic reviews and meta-
analysis should be as comprehensive as possible and
should therefore not preclude the inclusion of trials
because of language reasons.
In order to support reviewers the Cochrane Collaboration
organised an international project to manually search the
health care literature from many countries for RCTs. The
trials identified are added to the Cochrane Controlled Tri-
als Register and thus made available to reviewers.
Methods
Eight German language general health care journals (and
their predecessors) were manually searched for the years
1948 to 2004: Deutsche Medizinische Wochenschrift, Journal
of Molecular Medicine (formerly Klinische Wochenschrift),
Medizinische Klinik,  Medizinische Welt,  Münchener
Medizinische Wochenschrift, Swiss Medical Weekly (formerly
Schweizerische Medizinische Wochenschrift),  Wiener
Medizinische Wochenschrift, Zeitschrift für Allgemeinmedizin.
The sample sizes of the identified trials were extracted and
analysed in groups of three consecutive calendar years.
Results
1618 RCTs were published as original articles with a
median total number of patients of 43 (quartiles 20 and
87). Only 19.3% of the identified trials included more
than 100 patients. The number of published trials was
very low between 1948 and 1970 and increased between
1970 and 1986 to a maximum of 11.2 RCTs per journal
and year (figure 1). In the following time period a striking
decline of the number of RCTs was observed. Between
1999 and 2001 only 0.8 RCTs per journal and year were
published on average. In the last analysed time period
(2002–2004) an increase in the number of published tri-
als can be observed: 1.7 trials per journal and year were
published.
Personal communication with editors of the journals
resulted in a fairly uniform explanation of this trend: The
widespread introduction of using journal impact factors
for the allocation of resources has strongly motivated
researchers to publish in higher impact journals. As these
are almost entirely in English, German general health care
journals now rarely receive RCTs for publication.
Concerning the trial size, a slight but steady increase of the
number of patients per trial can be observed. The median
number of patients per trial rose from 30 in the years 1969
to 1971 to 60 between 2002 and 2004.
Discussion
The number of RCTs published in the German language
general health care literature has declined dramatically
between 1986 and 2001. Between 1999 and 2001 eight
major German language general health care journals pub-
lished only 20 RCTs.
This observation confirms developments in other general
health care journals, but is in clear contrast to high impact
international general and specialist journals where a con-
stant number of RCTs has been observed over past dec-
ades [5-7].
The slight increase of the number of published trials in the
years 2002 to 2004 can (partially) be explained by
changes of publication language from German to English
in three of the analysed journals (more than 50% of the
39 RCTs published between 2002 and 2004 were in Eng-
lish language).
The sample size of trials identified in German language
general health care journals was small with an increase in
the more recent volumes. Although the trial size
increased, it remains even in recent years rather small with
a median number of 60 patients per trial. The average
sample size of RCTs published in German appears to be
comparable to other general health care journals and spe-
cialist journals, however, trials published in international
journals of high impact are considerably larger [5,7]. The
proportion of RCTs with 100 or more patients published
in the BMJ and the Annals of Internal Medicine in the years
1995–1997 was 76% compared to 19.3% in the investi-
gated German language journals [5].
The observed decline of RCTs published in German lan-
guage general health care journals raises the question
whether the number of trials is declining or whether trials
nowadays are more frequently not published or published
elsewhere. Currently German ethics committees do not
know the exact number of approved RCTs because their
records do not distinguish between different study
designs. We can only speculate whether an increasing pro-
portion of these trials is never published, or where these
trials have been published in recent years. What can be
concluded is that the leading general health care journals
in the German language area have abandoned their role inBMC Medical Research Methodology 2006, 6:30 http://www.biomedcentral.com/1471-2288/6/30
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the dissemination of RCTs. However, the change of the
publication language from German to English (as in the
Schweizerische Medizinische Wochenschrift – now swiss
Medical Weekly) resulted in a contrasting development
with an increase of the number of published RCTs.
Conclusion
Allocation of funding resources and the scientific career
depend to a great extent on the value of the scientific out-
put (measured by impact factor points) of an institution
or an individual researcher. The result is an increasingly
fierce competition for publication in high impact jour-
nals, with high rejection rates, influencing the chance to
get manuscripts published in due time. German-language
RCTs, and those from comparable non-English language
countries, face far more obstacles to publication than a
decade ago when they were easily submitted to German-
language or other non-English language journals, with a
good chance of being accepted for publication. It is
unclear how these changes in dissemination patterns
affect the validity of systematic reviews and meta-analyses,
and, generally, the transfer of knowledge from research
into practice. Prospective trial registration, frequently stip-
ulated but not implemented universally, would allow
tracking trials from ethics committee approval to publica-
tion and help prevent under- and overreporting [8]. This
study adds another piece of evidence to the urgent need
for more transparency in the dissemination process, as it
is intended by the present initiative of WHO [9]. In this
initiative WHO has taken the lead to establish a standard-
ized, global framework for the prospective registration of
clinical trials as e.g. required by the International Com-
mittee of Medical Journal Editors (ICMJE) to reduce
biases in the reporting and publication process of clinical
trials and thus improve the base for decision making in
health care [10].
Number and Size of RCTs published in eight German language general health care journals Figure 1
Number and Size of RCTs published in eight German language general health care journals.
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